Dirk R. Gewert

3.0k total citations · 1 hit paper
44 papers, 2.6k citations indexed

About

Dirk R. Gewert is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dirk R. Gewert has authored 44 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Immunology and 18 papers in Oncology. Recurrent topics in Dirk R. Gewert's work include Cytokine Signaling Pathways and Interactions (14 papers), interferon and immune responses (13 papers) and Immune Response and Inflammation (7 papers). Dirk R. Gewert is often cited by papers focused on Cytokine Signaling Pathways and Interactions (14 papers), interferon and immune responses (13 papers) and Immune Response and Inflammation (7 papers). Dirk R. Gewert collaborates with scholars based in United Kingdom, Canada and United States. Dirk R. Gewert's co-authors include Bryan Williams, Agnès Le Bon, Nathalie Etchart, David F. Tough, Sam Hou, Persephone Borrow, Miranda Ashton, Andrew C.G. Porter, Michael J. Clemens and George R. Stark and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Dirk R. Gewert

44 papers receiving 2.5k citations

Hit Papers

Cross-priming of CD8+ T cells stimulated by virus-induced... 2003 2026 2010 2018 2003 200 400 600

Peers

Dirk R. Gewert
Oxana A. Malakhova United States
Michael P. Malakhov United States
Bhavin S. Parekh United States
Nitin Raj United States
Paul Domanski United States
Stephen J. Ullrich United States
Wei-Chun Au United States
Lara S. Izotova United States
Oxana A. Malakhova United States
Dirk R. Gewert
Citations per year, relative to Dirk R. Gewert Dirk R. Gewert (= 1×) peers Oxana A. Malakhova

Countries citing papers authored by Dirk R. Gewert

Since Specialization
Citations

This map shows the geographic impact of Dirk R. Gewert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk R. Gewert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk R. Gewert more than expected).

Fields of papers citing papers by Dirk R. Gewert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk R. Gewert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk R. Gewert. The network helps show where Dirk R. Gewert may publish in the future.

Co-authorship network of co-authors of Dirk R. Gewert

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk R. Gewert. A scholar is included among the top collaborators of Dirk R. Gewert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk R. Gewert. Dirk R. Gewert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roche-Molina, Marta, Cristina Sánchez‐Ramos, David Sanz‐Rosa, et al.. (2020). The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis. Scientific Reports. 10(1). 11636–11636. 30 indexed citations
2.
Price, Karen, Meenhard Herlyn, Carolyn L. Dent, Dirk R. Gewert, & Claire Linge. (2005). The prevalence of interferon-alpha transcription defects in malignant melanoma. Melanoma Research. 15(2). 91–98. 3 indexed citations
3.
Sharp, Tyson V., et al.. (1999). Activation of the Interferon-Inducible (2′-5′) Oligoadenylate Synthetase by the Epstein–Barr Virus RNA, EBER-1. Virology. 257(2). 303–313. 26 indexed citations
4.
Dent, Carolyn L., et al.. (1996). Relative Transcriptional Inducibility of the Human Interferon-α Subtypes Conferred by the Virus-Responsive Enhancer Sequence. Journal of Interferon & Cytokine Research. 16(2). 99–107. 16 indexed citations
5.
Sharp, Nigel A., et al.. (1996). Expression and Purification of Recombinant, Glycosylated Human Interferon Alpha 2b in Murine Myeloma NSo Cells. Protein Expression and Purification. 7(4). 335–342. 28 indexed citations
6.
Linge, Claire, et al.. (1995). Interferon system defects in human malignant melanoma.. PubMed. 55(18). 4099–104. 35 indexed citations
7.
Lin, Rongtuan, Dirk R. Gewert, & John Hiscott. (1995). Differential Transcriptional Activation in Vitro by NF-κB/Rel Proteins. Journal of Biological Chemistry. 270(7). 3123–3131. 89 indexed citations
8.
Gewert, Dirk R., et al.. (1995). Detection of Rare Allelic Variants of the Interferon-α 2 Gene in Human Genomic DNA. Journal of Interferon & Cytokine Research. 15(5). 403–406. 8 indexed citations
10.
Crowe, Jenny, Dirk R. Gewert, Andrew Lewis, et al.. (1994). Interferon (IFN)- 2 Genotype Analysis of Chinese Chronic Hepatitis B Patients Undergoing Recombinant IFN- 2a Therapy. The Journal of Infectious Diseases. 169(4). 875–878. 13 indexed citations
11.
Lin, Rongtuan, et al.. (1994). Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. Journal of Biological Chemistry. 269(26). 17542–17549. 65 indexed citations
12.
Gewert, Dirk R., et al.. (1993). Analysis of Interferon-α2 Sequences in Human Genomic DNA. Journal of Interferon Research. 13(3). 227–231. 15 indexed citations
13.
Sharp, Tyson V., Qiurong Xiao, Ian W. Jeffrey, Dirk R. Gewert, & Michael J. Clemens. (1993). Reversal of the double‐stranded‐RNA‐induced inhibition of protein synthesis by a catalytically inactive mutant of the protein kinase PKR. European Journal of Biochemistry. 214(3). 945–948. 33 indexed citations
14.
Peakman, Timothy C., Robert A. Harris, & Dirk R. Gewert. (1992). Highly efficient generation of recombinant baculoviruses by enzymatically mediated site-specificin vitrorecombination. Nucleic Acids Research. 20(3). 495–500. 37 indexed citations
15.
Peakman, Timothy C., et al.. (1992). Enhanced expression of recombinant proteins in insect cells using a baculovirus vector containing a bacterial leader sequence. Nucleic Acids Research. 20(22). 6111–6112. 9 indexed citations
16.
Peakman, Timothy C., Charles H. Reynolds, Jonathan D. Moore, et al.. (1992). Expression of the mouse c-abl type IV proto-oncogene product in the insect cell baculovirus system. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1138(1). 68–74. 2 indexed citations
17.
Ackrill, Andrew M., Christopher S. Gilbert, Dirk R. Gewert, et al.. (1991). Differential response of the human 6–16 and 9–27 genes to α and γ interferons. Nucleic Acids Research. 19(3). 591–598. 38 indexed citations
18.
Crowe, J.S., Helen J. Cooper, M. A. Smith, et al.. (1991). Improved cloning efficiency of polymerase chain reaction (PCR) products after proteinase K digestion. Nucleic Acids Research. 19(1). 184–184. 125 indexed citations
19.
Rysiecki, G, Dirk R. Gewert, & Bryan Williams. (1989). Constitutive Expression of a 2′,5′-Oligoadenylate Synthetase cDNA Results in Increased Antiviral Activity and Growth Suppression. Journal of Interferon Research. 9(6). 649–657. 119 indexed citations
20.
Peakman, Tim, Martin Pagé, & Dirk R. Gewert. (1989). Increased recombinational efficiency in insect cells irradiated with snort wavelength ultra-violet light. Nucleic Acids Research. 17(13). 5403–5403. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026